Julio Cesar Albarracin

Julio Albarracin practices at Key Whitman Surgery Center in Dallas, Texas.

Julio Albarracin's NPI, 1902301781, was assigned on March 26, 2018. Julio Albarracin graduated from McGovern Medical School in 2018. Julio Albarracin holds Texas license U2428.

Julio Albarracin's primary practice is Key Whitman Surgery Center, at 11442 N. Central Expressway, Dallas, TX 75243. The practice phone is (214) 754-0000.

Julio Albarracin's primary practice is Key Whitman Surgery Center in Dallas, Texas. Dmand AI also links Julio Albarracin to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Julio Albarracin practices. Vendor and product names are available with a free account.

Ophthalmology is Julio Albarracin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Julio Albarracin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Julio Albarracin's licenses on file in 4 states: Texas, Georgia, District of Columbia and Virginia.

Dmand AI lists cataract, conjunctivitis, dry eye, eye infection or inflammation, glaucoma, hereditary corneal conditions, inflammation of iris and secondary membranaous cataract surgery among the conditions Julio Albarracin treats.

CMS data shows 848 Medicare services from Julio Albarracin across 13 procedure codes in 2024, for 358 Medicare patients. Medicare paid $100,940 for them.

CMS counts 358 Medicare patients who saw Julio Albarracin in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Julio Albarracin's median patient age at 69, with 56% women.

In 2024, Julio Albarracin wrote 1,222 Medicare Part D claims for 485 patients. 48% of them were for generic drugs. CMS names the drug for 1,108 of them, across 16 drugs with 11 or more claims each, at $95,276 in total drug cost. In 2023, CMS named 658 claims across 15 drugs.

Julio Albarracin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 301 procedures of cataract surgery by Julio Albarracin, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Julio Albarracin in 2017. Julio Albarracin's most frequent co-author is Jordan D. Desautels, MD.

CMS Open Payments shows 141 general payments to Julio Albarracin from 20 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 50% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $4,905.

Julio Albarracin graduated from McGovern Medical School in 2018.

Julio Albarracin is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.